Surface Pharmaceuticals' Series A Round

Surface Pharmaceuticals raised a round of funding on May 15, 2018. Investors include Flying L Partners.

Surface Pharmaceuticals is a drug development company working on treatments for dry eye and blepharitis. Surface's pipeline includes eye drops SURF-100 and SURF-200, which combine the generic medicati…

Articles about Surface Pharmaceuticals' Series A Round: